Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early switch to oral antibiotics in low-risk neutropenic sepsis
ISRCTN84288963Phase 4Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Nov 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 4 trial of ciprofloxacin, amoxicillin + clavulanate, piperacillin + tazobactam and meropenem, sponsored by Belfast Health and Social Care Trust. Started Nov 2015; status: completed.
02
Drugs
ciprofloxacinamoxicillin + clavulanatepiperacillin + tazobactammeropenem
Beyond the preview
Go deeper on ISRCTN84288963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN84288963.